New chair and deputy chair of women on boards review will champion female executives
A New chair and deputy chair of women on boards review have been appointed.
The Chair of GlaxoSmithKline, and former Chair of RBS and Sainsbury’s, Sir Philip Hampton, has been appointed to lead an independent review on increasing representation of women in the executive level of FTSE 350 companies, the government has announced.
Dame Helen Alexander, Chair of UBM, will take on the role of Deputy Chair to the review.
Sir Philip’s new review will continue on from Lord Davies’s Women on Boards Review, a voluntary business led initiative, which saw female representation on boards in the FTSE 100 rise from 12.5% to beyond the target of 25%.
The next phase of the review will focus on building the pipeline for female executives and emerging non-executive directors, to continue the work already done on increasing board representation. This was one of the key recommendations from Lord Davies’s report.
Business Secretary Sajid Javid said:
The employment rate for women has never been higher and there are now more women on FTSE boards than ever before. But we need to go further, particularly when it comes to paving the way to the executive level. Companies cannot afford to miss out on the skills and talent of the whole population if the UK is going to compete in a fast-moving global economy. This is not just about diversity for diversity’s sake, but about improving performance and productivity.
Sir Philip brings a wealth of business experience to this important role, and he has an impressive track record of creating a culture where women can thrive and succeed.
Women and Equalities Minister Nicky Morgan said:
Having more women on FTSE boards allows companies to benefit from the enormous wealth of talent these women offer, and means these women can act as powerful role models for the next generation of girls.
We have come a long way but we must do more to make sure women everywhere are able to fulfil their potential. I want to see an end to all male boards anywhere on the FTSE 350, and much more progress at the executive layer where we know progress has been slowest to date. Men have a critical role to play in this and I look forward to working with Sir Philip and his team on this incredibly important agenda.
Sir Philip Hampton has been Chair at GlaxoSmithKline since May 2015. Before joining GSK, he was Chair of The Royal Bank of Scotland Group and J Sainsbury plc. Before that he was Group Finance Director at Lloyds TSB Group, BT Group plc, BG Group plc, British Gas and British Steel plc.
He led the Hampton Review of regulatory inspection and enforcement in 2005 and was also Chair of UK Finance Investments Limited in 2008.
Sir Philip Hampton said:
I am delighted to take on Lord Davies’s great work around Women on Boards and I want to now turn my attention to the FTSE 350. I will focus on improving representation in the executive layer of companies, as well as maintaining the momentum on boards. This means looking at the talent pipeline for female executives and emerging non-executive directors to ensure we create opportunities and the right conditions for women to succeed.
In his first move as Chair, Sir Philip has appointed Dame Helen Alexander as his Deputy Chair to work alongside him on the review. Dame Helen is Chair of UBM plc and also a non-executive director of Rolls-Royce Group plc, Huawei UK, and a senior adviser to Bain Capital.
Corporate Governance Minister Baroness Neville-Rolfe, said:
As a former director of several companies, I know that business needs to do more to ensure that female talent is harnessed and not wasted. Encouraging progress has been made, but we now need to focus on the talent pipeline of capable women to ensure they can see a viable way ahead into leadership positions.
This will ultimately make companies more innovative and more competitive; a leadership team made up of men and women better represents the employee and customer base giving firms an edge in the products and services they offer.
Notes to editors
- Both Sir Philip and Dame Helen were chosen to lead the independent review because of their extensive combined experience at executive and non-executive levels. Both have a good track record of women on boards at the firms they’ve worked at, and are well respected across the FTSE 350.
- Terms of reference for the review will be finalised but the overall aims of the work would be to: * continue to champion work to improve representation of women on FTSE 350 boards * consider options for building the talent pipeline, focussing on improving representation of women in the executive layer of FTSE 350 companies
- Sir Philip Hampton * currently Chair of GlaxoSmithKline (from May 2015) with 27% representation of women on their board. Also Senior Independent Director of Anglo American * previous positions include Chair of Royal Bank of Scotland; Chair of Sainsbury’s; Group Finance Director of Lloyds Banking Group; Group Finance Director of BT; Finance Director of BG
- Dame Helen Alexander * joined the Board of UBM plc on 10 May 2012 * currently a Non-Executive Director of Rolls-Royce Group plc (FTSE 100) and senior adviser to Bain Capital * she was formerly Chair of the Port of London Authority * she is Chancellor of the University of Southampton and is currently involved with other not-for-profit organisations in media, the arts and education